Luxury Lounge Aesthetics & IV Wellness

Luxury Lounge Aesthetics & IV Wellness operates in Wolfforth, Texas, providing medical weight loss programs, aesthetic treatments, and intravenous nutrient therapy under the clinical direction of Krystal Avalos, FNP-C. The clinic serves patients throughout the Lubbock metropolitan area with in-person consultations and treatment protocols designed for adults seeking physician-supervised weight management and cosmetic enhancement. Avalos holds board certification as a Family Nurse Practitioner and structures treatment plans around individual metabolic profiles, body composition analysis, and patient-specific health goals rather than standardized protocols.

The medical weight loss program centers on GLP-1 receptor agonist therapy using Semaglutide and Tirzepatide, both FDA-approved medications that regulate appetite and glucose metabolism. Semaglutide is administered as a once-weekly subcutaneous injection starting at 0.25 mg with titration based on tolerance and weight loss velocity. Tirzepatide, a dual GIP/GLP-1 receptor agonist, follows a similar dosing schedule beginning at 2.5 mg weekly. Avalos monitors patients through regular body composition assessments, metabolic panels, and adjustment of dosing schedules to optimize fat loss while preserving lean muscle mass. The clinic does not offer cookie-cutter programs; each patient receives individualized caloric targets, macronutrient ratios, and exercise recommendations based on their starting metabolic rate and lifestyle constraints. Patients typically schedule follow-up appointments every four weeks during the active weight loss phase.

Beyond peptide-based weight management, Luxury Lounge Aesthetics provides neuromodulator injections including Botox for dynamic wrinkles, dermal fillers for volume restoration, and targeted skin care protocols. The aesthetic services integrate with the weight loss programs, as many patients pursuing significant weight reduction also address skin laxity and facial volume changes. Avalos performs cosmetic injections in the same clinical setting where metabolic consultations occur, allowing patients to consolidate appointments. The IV therapy menu includes hydration formulations, vitamin infusions, and immune support protocols administered in private treatment rooms. Kenalog injections are available for inflammatory conditions when clinically appropriate, and the clinic maintains relationships with dermatology and endocrinology specialists in Lubbock for cases requiring co-management.

Patients schedule an initial consultation at the Wolfforth location where Avalos conducts a health history review, discusses prior weight loss attempts, reviews current medications, and orders baseline laboratory work including comprehensive metabolic panel, lipid profile, hemoglobin A1c, and thyroid function tests. The clinic does not accept insurance for weight loss services; patients pay out-of-pocket with transparent pricing provided before treatment initiation. Semaglutide and Tirzepatide are dispensed through partner pharmacies with prescriptions written by Avalos following the consultation. Follow-up visits include weight checks, blood pressure monitoring, review of food logs, and assessment for medication side effects such as nausea or gastrointestinal changes. Patients receive direct access to the clinical team through a patient portal for questions between scheduled appointments.

Luxury Lounge Aesthetics operates exclusively through in-person visits at the Wolfforth clinic and does not currently offer telehealth consultations or remote prescribing. This model allows Avalos to perform hands-on assessments, administer injections on-site, and maintain direct oversight of treatment progression. The clinic's location in Wolfforth positions it as an accessible option for residents of western Lubbock County and surrounding communities who prefer local access to medical weight loss rather than traveling to larger metropolitan centers. Avalos maintains active licensure in Texas and completes continuing education in obesity medicine, aesthetic injectables, and peptide therapeutics to ensure clinical protocols reflect current evidence and safety standards.